This post was originally published on this site
But the increasing prevalence of chronic diseases throughout the world is also expected to drive the demand for pharma products. Furthermore, the digital revolution in providing life-transforming treatments to patients and increasing investments in R&D to develop efficient drugs to fight various critical health conditions are expected to be the major growth drivers of pharmaceutical companies. Consequently, the global pharmaceuticals market is expected to hit $1,700.97 billion in 2025, registering an 8% CAGR
Given this backdrop, shares of leading pharmaceutical companies with resilient business models—Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY)—hold solid upside potential. So, we believe these two stocks could be solid buy-and-hold bets for the next 10 years.
